1. Stocks
    2. /
  2. Immutep Limited (ASX: IMM)
    3. /

Immutep Limited (ASX: IMM) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Immutep Limited Chart and Price Data

Fundamentals Data provided by Morningstar.

Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

    • Immutep Limited (ASX: IMM)
    Latest News

    Medical workers examine an xray or scan in a hospital laboratory.
    Healthcare Shares

    Up 34% since September, ASX 300 healthcare share lifts off on big German news

    | Bernd Struben

    The ASX biotech company is grabbing investor interest amid the latest news from Germany.

    Read more »

    Scientists in a laboratory look at a computer screen with anticipation on their faces representing a potential change in the performance of ASX biotech shares in FY23
    Broker Notes

    Looking for a biotech multi-bagger? This could be the one.

    | Cameron England

    This stock could re-rate significantly if its cancer clinical trials deliver as hoped.

    Read more »

    Doctor doing a telemedicine using laptop at a medical clinic
    Healthcare Shares

    Up 34% since April, ASX 300 healthcare stock lifts off again today on new milestone

    | Bernd Struben

    The ASX 300 healthcare stock has been on a tear since hitting one-year lows in April.

    Read more »

    Beautiful young woman drinking fresh orange juice in kitchen.
    Healthcare Shares

    Guess which ASX 300 stock is jumping 11% on big news

    | James Mickleboro

    This stock is having a day to remember on Thursday. But why?

    Read more »

    Man with rocket wings which have flames coming out of them.
    Share Gainers

    Guess which ASX All Ords share just rocketed 19% on BIG news

    | Bernd Struben

    Investors are sending this ASX All Ords share flying on Monday. But why?

    Read more »

    In the lab at work, the mature adult woman and young adult man smile as they review the results of their successful experimentation.
    Healthcare Shares

    ASX 300 healthcare stock lifts off on promising new results

    | Bernd Struben

    Up 28% in a year, the ASX healthcare stock is leaping higher on Thursday.

    Read more »

    Businesswoman holds hand out to shake.
    Mergers & Acquisitions

    Is this ASX All Ords stock primed for a takeover offer in 2025?

    | Bernd Struben

    The ASX All Ords stock could draw the interest of global companies saddled with fading patents.

    Read more »

    A person with a round-mouthed expression clutches a device screen and looks shocked and surprised.
    Small Cap Shares

    Guess which small cap ASX share could rise 100%+

    | James Mickleboro

    A leading broker is tipping big returns from this speculative stock.

    Read more »

    drug capsule opening up to reveal dollar signs signifying rising asx share price
    Healthcare Shares

    3 ASX healthcare shares going gangbusters on Thursday

    | Bernd Struben

    Investors are sending these ASX healthcare stocks soaring today. But why?

    Read more »

    Happy, tablet or doctor in a laboratory with research results or positive feedback after medical data analysis. Smile, vaccine or healthcare worker reading or working on futuristic science innovation.
    Healthcare Shares

    4 ASX healthcare stocks having a cracking run on Friday

    | James Mickleboro

    These shares are making their shareholders smile on Friday. What's happening?

    Read more »

    Shot of a young businesswoman looking stressed out while working in an office.
    Share Fallers

    Why Cettire, Immutep, Paladin Energy, and Westgold shares are sinking today

    | James Mickleboro

    These shares are starting the week in the red. But why?

    Read more »

    Shot of a young scientist using a digital tablet while working in a lab.
    Healthcare Shares

    Guess which ASX healthcare stock is surging on big FDA news

    | Zach Bristow

    The update is a critical milestone for the company.

    Read more »

    Frequently Asked Questions

    No, Immutep does not pay dividends at this time.

    Immutep Ltd listed on the ASX on 23 June 1988.

    IMM ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Immutep Limited

    Immutep Ltd (ASX: IMM) is a biotechnology company developing immunotherapy products for cancer and autoimmune diseases. The company describes itself as a pioneer in the understanding and advancement of therapeutics related to Lymphocyte Activation Gene-3 (LAG-3), a cell surface molecule that plays a vital role in regulating the immune system. Immutep's LAG-3 immunotherapies are designed to harness and strengthen the power of patients' immune systems to fight cancer and autoimmune diseases. Immutep currently has three clinical-stage candidates and two earlier-stage candidates.

    Profile

    since

    Note